Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Single-blind Study on the Effects of Psychosomatic Symptom Interventions on Patients With Differentiated Thyroid Cancer During the Initial Treatment Period
The psychosomatic symptoms of patients with differentiated thyroid cancer (DTC) during the initial treatment phase need to be improved. Stress coping training aims to reshape an individual's perception of stress and provide skill training, thereby influencing how they cope in stressful situations. Symptom management theory emphasizes improving health outcomes by helping individuals perceive and manage their symptoms. Therefore, this clinical trial combines stress coping training and symptom management theory to construct and test an intervention program for psychosomatic symptoms in DTC patients. The main questions it aims to answer are: * Does the psychosomatic symptom intervention alleviate participants' levels of anxiety and depression? * Does the psychosomatic symptom intervention promote participants' achievement of TSH suppression therapy standards? * Does the psychosomatic symptom intervention enhance participants' self-management efficacy? * Does the psychosomatic symptom intervention improve participants' shoulder joint function? Researchers will compare the psychosomatic symptom intervention with continuous psychological care (a form of comforting care) to determine if the intervention better promotes participants' psychosomatic health. 1. Before conducting this clinical trial, researchers conducted qualitative interviews with DTC patients and healthcare providers, followed by literature analysis and expert consultations to develop a psychosomatic symptom intervention program for DTC patients during the initial treatment phase. 2. A total of 84 DTC patients in the initial treatment phase were recruited and randomly grouped into two blocks. The intervention group received a 12-week psychosomatic symptom intervention in addition to routine care, while the control group received 12 weeks of continuous care. Data were collected before the intervention, at the end of the intervention, 3 months after the intervention, and 6 months after the intervention. The psychosomatic symptom intervention mainly includes: * Psychological module: symptom logs, meditation, positive psychology, and emotional management * Physiological module: gargling exercises, "T" exercises, "米" exercises, and shoulder-neck exercises * The psychosomatic module aims to intervene at three levels: individual, environmental, and health and disease. The individual level includes role management and self-awareness. The environmental level includes resource utilization, family support, peer support, and social support. The health and disease level includes disease management, individual counseling, and progressive muscle relaxation training. * The intervention is divided into three stages: concept formation, skill acquisition and repetition, and application and completion. These stages are further divided into six sub-stages, each containing content from the psychological, physiological, and psychosomatic modules.
Age
18 - 60 years
Sex
ALL
Healthy Volunteers
No
Harbin Medical University
Harbin, Heilongjiang, China
Start Date
August 1, 2023
Primary Completion Date
January 22, 2024
Completion Date
April 22, 2025
Last Updated
February 18, 2025
84
ESTIMATED participants
Psychosomatic Symptoms Intervention
OTHER
Extended supportive care
OTHER
Lead Sponsor
Harbin Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions